We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Physio-Control

Physio-Control develops, manufactures, sells and services external defibrillator/monitors and emergency medical respo... read more Featured Products: More products

Download Mobile App




Innovative Crossing Catheter Tackles Critical Limb Ischemia

By HospiMedica International staff writers
Posted on 09 Mar 2014
A new crossing catheter targets challenging ischemic lesions in the lower extremities, including those in below-the-knee (BTK) arteries. More...


The TOTAL across crossing catheter is intended to guide and support a 0.355 mm guidewire in order to improve blood flow through narrowed or occluded lower-extremity arteries associated with critical limb ischemia (CLI) that would otherwise be inaccessible with larger catheters. The interventional guidewires can be swapped out as necessary, and the catheter can also be used to pump through saline solutions or diagnostic contrast agents.

Feature of the crossing catheter include a spiral-cut stainless steel hypotube construction, which affords exceptional pushability and unparalleled catheter visualization, and a 0.06 mm (2-French) tapered tip that allows the catheter to cross lesions smaller than the device profile. The TOTAL across crossing catheter is a product of Medtronic (Minneapolis, MN, USA), and has received the Conformité Européene (CE) marking of approval.

“The TOTAL across crossing catheter expands our portfolio of medical devices for the interventional treatment of peripheral artery disease,” said Tony Semedo, senior vice president at Medtronic and president of the company's Endovascular Therapies business. “It's a prime example of our focus on developing lesion-specific solutions and our ongoing commitment to addressing BTK lesions specifically.”

“The TOTAL across crossing catheter represents a tangible step forward in microcatheter design, providing extraordinary support, and stability combined with one of the lowest crossing profiles available to better deal with the clinical challenge of distal BTK revascularization,” said angiologist and cardiologist Andrej Schmidt, MD, of Park-Hospital Leipzig (Germany).

CLI is a severe blockage in the arteries of the lower extremities, which markedly reduces blood-flow; it is a serious form of peripheral arterial disease (PAD), but less common than claudication. PAD is caused by atherosclerosis, and results in severe pain in the feet or toes, even while resting, due to poor circulation. Complications include sores and wounds that will not heal in the legs and feet that if left untreated, could result in amputation of the affected limb.

Related Links:

Medtronic
Park-Hospital Leipzig



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.